Converting wave motion into electricity holds enormous potential as a renewable energy source, but a lack of standardized prototyping is holding back technological development. A research team led by ...

Reza Pahlavi, the son of the late deposed shah of Iran, said he hopes to help lead a transitional government in his home ...

Over his more than two decades as a clean energy entrepreneur and commentator, Jigar Shah has established himself as one of ...

The city issued a construction permit Jan. 8 to The Haskell Co. for the first phase to convert the former Tyson Foods Inc. plant in Northwest Jacksonville into a facility for Thomas Foods ...

Secretary of Defense Pete Hegseth and Secretary of State Marco Rubio speak to reporters after they briefed Senators on the recent US military actions in Venezuela, on Capitol Hill in Washington on Jan ...

Abstract: A control method of a Matrix Converter to convert from four-wired three-phase voltages to three-wired single-phase voltages (single-phase MC) which replaces transformer in consumer side on ...

Insights, news and analysis of the crypto market straight to your inbox ...

Abstract: This article proposes a control strategy for the three-phase single-stage matrix-type LCL resonant ac–dc converter. A five-level voltage is generated through the matrix converter, and the ...

Regeneron is racing to regulators after reporting a phase 3 win in an ultrarare disease. The biotech plans to file for FDA approval of garetosmab in fibrodysplasia ossificans progressiva (FOP) by the ...

India is actively negotiating a three-phase trade agreement with the U.S. and expects to finalize an interim agreement before July, when Trump's reciprocal tariffs are set to take effect, Bloomberg ...

A phase converter provides three-phase power from a single-phase source. Old-style mechanical converters use a hybrid motor/generator, while electronic converters use capacitors and other devices to ...

Novartis has committed another $1.7 billion to its ambition to become a kidney disease leader. The Swiss drugmaker is making the outlay, around half of which is upfront, to buy Regulus Therapeutics ...